Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Copeland

Showing results (351-360 of 449) with videos related to

Pageof 45
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1995
The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanismS Gilbertson-Beadling, E A Powers, M Stamp-Cole, et al.
Obstetrics and Gynecology|November 2, 2006
Improved survival with an intact DNA mismatch repair system in endometrial cancerDavid E Cohn, Wendy L Frankel, Kimberly E Resnick, et al.
The Oncologist|August 17, 2021
Endometrial Cancer: Who Lives, Who Dies, Can We Improve Their Story?Casey M Cosgrove, Floor J Backes, David O'Malley, et al.
Gynecologic Oncology|September 26, 2022
The contemporary presentation and diagnosis of endometrial cancer recurrence: When, where, and how?Courtney J Riedinger, Jenna M Patterson, Floor J Backes, et al.
Gynecologic Oncology|June 10, 2014
A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancerEric L Eisenhauer, Vanna Zanagnolo, David E Cohn, et al.
Gynecologic Oncology|December 4, 2018
Outpatient desensitization of patients with moderate (high-risk) to severe platinum hypersensitivity reactionsMonica Hagan Vetter, Ambar Khan, Floor J Backes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 15, 2015
Documentation of Pregnancy Risk Assessment and Pregnancy Among Women Presenting for Gynecologic Oncology ConsultationSarah Crafton, Silpa Nekkanti, Courtney Lynch, et al.
Cancer|May 1, 1986
Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vinblastine, bleomycin, and cisplatinD M Gershenson, J J Kavanagh, L J Copeland, et al.
Gynecologic Oncology|October 5, 2018
Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer CenterAdam C ElNaggar, Erinn M Hade, David M O'Malley, et al.
Gynecologic Oncology|November 8, 2011
Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancerC I Nagel, F J Backes, E M Hade, et al.
Pageof 45

Showing results (351-360 of 449) with videos related to

Sort By:
Pageof 45
Cancer Chemotherapy and Pharmacology|January 1, 1995
The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanismS Gilbertson-Beadling, E A Powers, M Stamp-Cole, et al.
Obstetrics and Gynecology|November 2, 2006
Improved survival with an intact DNA mismatch repair system in endometrial cancerDavid E Cohn, Wendy L Frankel, Kimberly E Resnick, et al.
The Oncologist|August 17, 2021
Endometrial Cancer: Who Lives, Who Dies, Can We Improve Their Story?Casey M Cosgrove, Floor J Backes, David O'Malley, et al.
Gynecologic Oncology|September 26, 2022
The contemporary presentation and diagnosis of endometrial cancer recurrence: When, where, and how?Courtney J Riedinger, Jenna M Patterson, Floor J Backes, et al.
Gynecologic Oncology|June 10, 2014
A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancerEric L Eisenhauer, Vanna Zanagnolo, David E Cohn, et al.
Gynecologic Oncology|December 4, 2018
Outpatient desensitization of patients with moderate (high-risk) to severe platinum hypersensitivity reactionsMonica Hagan Vetter, Ambar Khan, Floor J Backes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 15, 2015
Documentation of Pregnancy Risk Assessment and Pregnancy Among Women Presenting for Gynecologic Oncology ConsultationSarah Crafton, Silpa Nekkanti, Courtney Lynch, et al.
Cancer|May 1, 1986
Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vinblastine, bleomycin, and cisplatinD M Gershenson, J J Kavanagh, L J Copeland, et al.
Gynecologic Oncology|October 5, 2018
Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer CenterAdam C ElNaggar, Erinn M Hade, David M O'Malley, et al.
Gynecologic Oncology|November 8, 2011
Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancerC I Nagel, F J Backes, E M Hade, et al.
Pageof 45